Rsk-2 Activity is Necessary for Epidermal Growth Factor-induced Phosphorylation of CREB Protein and Transcription of C-fos Gene
Overview
Authors
Affiliations
Activation by growth factors of the Ras-dependent signaling cascade results in the induction of p90 ribosomal S6 kinases (p90(rsk)). These are translocated into the nucleus upon phosphorylation by mitogen-activated protein kinases, with which p90(rsk) are physically associated in the cytoplasm. In humans there are three isoforms of the p90(rsk) family, Rsk-1, Rsk-2, and Rsk-3, which are products of distinct genes. Although these isoforms are structurally very similar, little is known about their functional specificity. Recently, mutations in the Rsk-2 gene have been associated with the Coffin-Lowry syndrome (CLS). We have studied a fibroblast cell line established from a CLS patient that bears a nonfunctional Rsk-2. Here we document that in CLS fibroblasts there is a drastic attenuation in the induced Ser-133 phosphorylation of transcription factor CREB (cAMP response element-binding protein) in response to epidermal growth factor stimulation. The effect is specific, since response to serum, cAMP, and UV light is unaltered. Furthermore, epidermal growth factor-induced expression of c-fos is severely impaired in CLS fibroblasts despite normal phosphorylation of serum response factor and Elk-1. Finally, coexpression of Rsk-2 in transfected cells results in the activation of the c-fos promoter via the cAMP-responsive element. Thus, we establish a link in the transduction of a specific growth factor signal to changes in gene expression via the phosphorylation of CREB by Rsk-2.
Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status.
Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C Signal Transduct Target Ther. 2025; 10(1):39.
PMID: 39948335 PMC: 11825823. DOI: 10.1038/s41392-024-02098-3.
Overexpressed RPS6KA1 and its potential diagnostic value in head and neck squamous cell carcinoma.
Hu C, Xie J, Fei X, Sun Y, Lei S, Yan X Discov Oncol. 2025; 16(1):60.
PMID: 39827419 PMC: 11743407. DOI: 10.1007/s12672-025-01799-7.
RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging data.
Spirrison A, Lannigan D Expert Opin Ther Targets. 2024; 28(12):1047-1059.
PMID: 39632509 PMC: 11801519. DOI: 10.1080/14728222.2024.2433123.
Chen W, Lee G, Jeung D, Byun J, Wu J, Li X Cell Death Discov. 2024; 10(1):442.
PMID: 39424777 PMC: 11492232. DOI: 10.1038/s41420-024-02208-8.
Multi-faceted regulation of CREB family transcription factors.
Chowdhury M, Haq M, Lee J, Jeong S Front Mol Neurosci. 2024; 17:1408949.
PMID: 39165717 PMC: 11333461. DOI: 10.3389/fnmol.2024.1408949.